First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.
-
Tschopp J
Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
-
L'Huillier AG
Pediatric Infectious Diseases Unit, University Hospitals of Geneva and Faculty of Medicine, Genève, Switzerland.
-
Mombelli M
Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
-
Mueller NJ
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zürich, Switzerland.
-
Khanna N
Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
-
Garzoni C
Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland.
-
Meloni D
Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland.
-
Papadimitriou-Olivgeris M
Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
-
Neofytos D
Transplant Infectious Diseases Unit, University Hospitals of Geneva and Faculty of Medicine, Genève, Switzerland.
-
Hirsch HH
Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
-
Schuurmans MM
Pulmonology, University Hospital Zurich, Zürich, Switzerland.
-
Müller T
Nephrology clinic, University Hospital Zurich, Zürich, Switzerland.
-
Berney T
Service of Transplantation, University Hospitals of Geneva and Faculty of Medicine, Genève, Switzerland.
-
Steiger J
Department for Transplantation Immunology and Nephrology, Basel, Switzerland.
-
Pascual M
Transplantation Center, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
-
Manuel O
Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
-
van Delden C
Transplant Infectious Diseases Unit, University Hospitals of Geneva and Faculty of Medicine, Genève, Switzerland.
Show more…
Published in:
- American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. - 2020
English
Immunocompromised patients may be at increased risk for complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, comprehensive data of SARS-CoV-2 infection in solid organ transplant (SOT) recipients are still lacking. We performed a multicenter nationwide observational study within the Swiss Transplant Cohort Study (STCS) to describe the epidemiology, clinical presentation, treatment and outcomes of the first microbiologically documented SARS-CoV-2 infection among SOT recipients. Overall, 21 patients were included with a median age of 56 years (10 kidney, 5 liver, 1 pancreas, 1 lung, 1 heart and 3 combined transplantations). The most common presenting symptoms were fever (76%), dry cough (57%), nausea (33%), and diarrhea (33%). Ninety-five percent and 24% of patients required hospital and ICU admission, respectively, and 19% were intubated. After a median of 33 days of follow-up, 16 patients were discharged, 3 were still hospitalized and 2 patients died. These data suggest that clinical manifestations of SARS-CoV-2 infection in middle-aged SOT recipients appear to be similar to the general population without an apparent higher rate of complications. These results need to be confirmed in larger cohorts.
-
Language
-
-
Open access status
-
bronze
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/82309
Statistics
Document views: 54
File downloads: